EDITORIAL
Accepted on 26 Jun 2025
Editorial: "Advancements in Drug Development: Exploring Bi-Specific Antibodies as Promising Therapeutic Strategies in Oncology"
doi 10.3389/fonc.2025.1651944
- 132 views
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Advancements in Drug Development: Exploring Bi-Specific Antibodies as Promising Therapeutic Strategies in Oncology
Advancements in Drug Development: Exploring Bi-Specific Antibodies as Promising Therapeutic Strategies in Oncology
3,646
Total downloads
14k
Total views and downloads
Articles
MINI REVIEW
Published on 10 Feb 2025
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
doi 10.3389/fonc.2025.1548446
- 2,633 views
REVIEW
Published on 22 Jan 2025
Natural killer cell engagers for cancer immunotherapy
doi 10.3389/fonc.2024.1483884
- 3,389 views
ORIGINAL RESEARCH
Published on 18 Oct 2024
Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion
doi 10.3389/fonc.2024.1474007
- 1,963 views
ORIGINAL RESEARCH
Published on 08 Mar 2022
Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model
doi 10.3389/fonc.2022.818641
- 4,377 views
- 6 citations
Published in
Frontiers in Oncology
Cancer Molecular Targets and Therapeutics
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore